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INTRODUCTION:  Eccrine  porocarcinoma  (EPC)  is a  rare  malignancy  of eccrine  sweat  glands.  It  is  often  seen
during  the  sixth  to eighth  decades  of life. We  report  the  ﬁrst  case  of  eccrine  porocarcinoma  arising  on
the  abdomen  of  a 21-year-old  patient  with  ulcerative  colitis.
CASE  PRESENTATION:  A  21-Year-old  female  presented  to  emergency  department  with  a  one  month  history
of an  enlarging  mass  over  left  lower  abdomen.  Abdominal  examination  revealed  a slightly  erythematous,
nodular  and  non-mobile  ﬁrm  mass  in  left lower  quadrant.  There  was  superﬁcial  ulceration  with  slight
serous  discharge.  CT  scan  of  the  abdomen  and  pelvis  with  contrast  revealed  a superﬁcial  cystic  lesion
over  the anterior  abdominal  wall,  provisionally  diagnosed  as  sebaceous  cyst.  Incision  and  drainage  were
performed  and  on  follow-up,  no  signs  of healing  were  observed  and the  patient  subsequently  underwent
surgical  excision.  Histopathological  examination  revealed  an  eccrine  porocarcinoma.
DISCUSSION:  EPC  is  a rare and  aggressive  tumor.  It may  occur  de  novo  or as  a result  of  malignant  transfor-
mation  of an eccrine  poroma.  A  long  period  of clinical  history  is often  encountered.  It usually  occurs  on
the  lower  extremities  followed  by the,  trunk,  head  and neck,  and  upper  extremities.  The  clinical  picture
usually  consists  of a painless  nodule  or papule.  Treatment  is  wide  local  excision.  No  strong  evidence  exists
for adjuvant  therapy.  The  risk  of  local  recurrence  is about  20%.
CONCLUSION:  High  index  of  suspicion  is required  for diagnosis  of EPC.  Early  diagnosis  is  achieved  by
histopathological  examination  and  early  deﬁnitive  surgical  excision  leads  to excellent  results.
© 2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Eccrine Porocarcinoma (EPC) is a rare and aggressive tumor with
n incidence of 0.005% to 0.01% of all epithelial cutaneous tumors
1]. It carries high risk of local recurrence, regional lymph node
nvasion, and distant metastasis. It is often seen during the sixth to
ighth decade of life, and most commonly affects the lower extrem-
ties [1]. To the best of our knowledge, this case represents the ﬁrst
eport of EPC arising on the abdomen of a patient with ulcerative
olitis (UC) and in the early 20′s.
. Case presentation
A 21-Year-old African American female presented to the emer-
ency department (ED) with a one month history of an enlarging
ass over left lower abdomen. The mass was ﬁrst noticed approx-
mately one month prior to presentation. There was no history of
ain, fever, malaise, nausea, vomiting, constipation, bloody diar-
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rhoea, or abdominal distension. Past medical history included UC
diagnosed nine months ago. Drug history included mesalamine
and prednisolone. Menstrual, surgical and family history were non-
contributory.
On examination, vital signs were normal. Abdominal exam-
ination revealed a non-distended, non-tender abdomen with a
3 cm × 2 cm × 2 cm,  slightly erythematous, nodular, ﬁrm and non-
mobile mass in left lower quadrant, with superﬁcial ulceration
and slight serous discharge. Laboratory investigations were non-
contributory. Computed Tomography (CT) scan of the abdomen and
pelvis with contrast revealed a 3.2 cm × 2.4 cm × 2.3 cm superﬁcial
cystic lesion over the anterior abdominal wall (Figs. 1 and 2). Upon
chart review, we noticed the mass present on a CT obtained four
months ago, howevr, was  overlooked at the time. The patient was
provisionally diagnosed with a questionable sebaceous cyst. Inci-
sion & drainage were performed yielding moderate serosanguinous
exudate. The wound was  left open to heal, and the patient was
discharged on a course of antibiotics.
A week later on follow up, no signs of healing were evi-
dent and the patient complained of a continuously discharging
wound. Consequently, she underwent surgical excision with pri-
mary wound closure. Histopathological examination of the excised
tissue revealed a poroid neoplasm originating from the overlying
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. CT scan of abdomen with contrast (axial view) showing an abdominal wall
mass 3.2 cm x 2.4 cm x 2.3 cm (white arrow).
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Fig. 3. Cystic space formation (black star) in eccrine porocarcinoma
(100 × magniﬁcation, H&E stain).
Fig. 4. Initial biopsy showing desmoplastic response (black arrows) and Islands of
tumor cells (black stars) in eccrine porocarcinoma (40× magniﬁcation, H&E  stain).ig. 2. CT scan of abdomen (sagittal view) showing anterior abdominal wall mass
white arrow).
pidermis and extending in lobules into the deep dermis to the
evel of the dermal-subcutaneous junction (Figs. 3–5). Immuno-
istochemical staining revealed tumor cells strongly positive for
ytokeratin 7 and cytokeratin p63, with focal immunoreactivity for
ytokeratin AE1/AE3 and epithelial membrane antigen (EMA). A
nal diagnosis of completely excised EPC with free but narrow mar-
ins was concluded. Follow-up CT scans of the chest, and abdomen
 pelvis with contrast revealed no signs of metastasis. Two weeks
ater, the patient underwent surgical re-excision with primary
ound closure to ensure wider safety margins, and was  discharged
he same day. Follow-up MRI  of the abdomen was within normal.
istopathological examination results after re-excision revealed
Fig. 5. Cohesive response of poroid cells in eccrine porocarcinoma (demarcated by
black arrows, 400× magniﬁcation, H&E stain).
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umor free margins. The patient continued to follow-up for ﬁve
onths and did well, after which she was lost to follow-up.
. Discussion
EPC is a rare malignancy of the intra-epidermal ductal portion
f eccrine sweat glands. The term ‘eccrine porocarcinoma’ was  ﬁrst
escribed in 1969 by Mishima and Morika [2]. The exact etiology
f EPC is unclear. It may  occur de novo or as a result of malignant
ransformation of long standing benign eccrine poroma. Expres-
ion of p53 protein may  have a role in the carcinogenesis of EPC [3].
he time to malignant transformation of a benign poroma is highly
ariable and can range from months to decades. A long period of
linical history is often encountered (up to 50 years), but rapid
evelopment within few months has also been reported [1].
EPC is most commonly seen in adults between 50 and 80 years of
ge with some predominance in the female gender [1,4]. It has also
een reported in children and young adults, the youngest being
n 8-year-old girl [5]. To date, we found only eight cases of EPC
eported in patients aged 25 years or younger [5–10]. EPC usually
rises on the lower extremities (44%), followed by the trunk (24%),
ead & neck (23%), upper extremities (11%), and rarely involves
ther areas [1]. To date, we  found only seven cases of EPC that have
een reported to arise on the abdomen, and all cases were greater
han 60-years of age [11–16]. To the best of our knowledge, this
ase represents the ﬁrst report of EPC arising on the abdomen of a
atient with UC and in the early 20s.
It is contended that similar to other neoplasms, the risk of EPC is
igher in patients who are immunosuppressed as a result of disease
r therapy [6]. Upon literature review, we did not encounter any
eports of EPC that occurred in patients with inﬂammatory bowel
isease (IBD). The base line risk for extra-intestinal solid tumors in
atients with IBD independent of therapy is less clear [17]. Addi-
ionally, there have been very few reports on the development of
ultiple eccrine poromas in immunosuppressed patients [18]. On
he other hand, Mahomed et al. suggested a possible role for ultra-
iolet radiation and chronic immunosuppression in the induction
f malignant squamous differentiation in a subset of patients with
PCs [6]. However, in our case, the patient received corticosteroid
herapy for only one month prior to presentation. Although tempt-
ng, it is difﬁcult to postulate that the patient was indeed at a higher
isk for development of a poroma or EPC due to UC or associated
mmunosuppression from therapy. However, one might hypothe-
ize that an association between UC and the development of EPC
ay possibly exist, but yet to be proven.
The clinical picture of EPC usually consists of a painless nod-
le or papule that increases in size over years to decades and
ay  ulcerate or bleed upon trauma [1]. The tumor size is vari-
ble and ranges from <1 cm to 10 cm.  Multinodularity, ulceration
nd rapid growth may  be associated with either local recurrence
r metastasis [1]. Diagnosis of EPC is mainly dependent on biopsy
nd histopathological examination with demonstration of either
n invasive architectural pattern, and/or cytological pleomorphism
ith eccrine differentiation. Cohesive basaloid squamous epithelial
ells are most commonly seen, however, other cell types including
pindle, clear, and mucin producing cells, or melanocytes may  be
resent [1]. Cellular atypia may  also be observed and is not nec-
ssarily suggestive of malignancy as it may  be similarly observed
n benign eccrine poroma. [1] Local or diffuse clear cell changes
ay  occur due to the glycogen content of tumor cells and may  be
dentiﬁed by positive staining with Periodic acid-Schiff (PAS) [1,4].
Differential diagnosis of EPC is wide and includes benign
nd malignant neoplasms of the skin, viscera, eccrine and apoc-
ine glands. Histologically, ductal differentiation of poromatous
pithelial cells is the hallmark of diagnosis. Due to simultaneousPEN  ACCESS
rgery Case Reports 23 (2016) 40–43
epidermoid differentiation, diagnosis of EPC may  be conﬁrmed
by immunohistochemical staining for carcinoembryonic antigen
(CEA), EMA, and p53 protein [1,3]. It has been demonstrated that
EMA  has higher positivity than CEA [4]. Positive staining for CEA
and/or EMA  highlights ductal differentiation and intracytoplasmic
lumina. However, luminal structure disappears in recurrent and
metastatic dedifferentiated lesions, rendering immunohistochemi-
cal staining for CEA and EMA  less useful. The use of immunostaining
for S-100 protein may  be the deﬁnite evidence for diagnosis of
recurrent and metastatic dedifferentiated EPC [19].
Tumor thickness tends to be the main prognostic factor for
EPC. Sentinel node biopsy has been useful for detecting micro-
metastasis to regional lymph nodes [1]. Tumors that are more than
7mms  in thickness, and more than 14 mitoses per high power ﬁeld
with lymph vascular space invasion tend to carry poor prognosis
[1,6].
Treatment often involves wide local excision with lym-
phadenectomy if regional lymph nodes were involved. Due to high
rate of local recurrence, wide excision of the primary tumor with
histologically clear margins is mandatory. Proper surgical resec-
tion leads to a curative outcome in 70–80% of cases. The risk of
local recurrence of EPC is about 20% [11]. Metastasis may  occur
either locally to regional lymph nodes or distantly, in about 20%
and 11% of cases respectively. The tumor tends to spread tangen-
tially in the lower third of the epidermis, then later inﬁltrates the
dermis, subcuticular fat and lymphatic system. Patients with EPC
and lymph node metastasis have an estimated mortality rate of 67%
[1]. Attempts using Mohs micrographic surgery have been reported
to reduce morbidity and local recurrence [20]. There is no strong
evidence or data available on the use of adjuvant therapy including
chemotherapy and radiotherapy for metastatic tumors [11].
4. Conclusion
EPC is a rarely encountered tumor that poses a diagnostic
challenge due to the lack of speciﬁc etiological factors and mor-
phological characteristics. No standard protocols or guidelines are
available for its diagnosis and management. High index of suspi-
cion should be maintained, and EPC should be considered in the
differential diagnosis of patients presenting with superﬁcial, cys-
tic abdominal wall masses, especially in the presence of ulceration
or serous discharge. Early diagnosis achieved by histopathological
examination in addition to early deﬁnitive surgical excision leads
to excellent results.
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